EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Recommendation of “Buy” from Brokerages
Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have been assigned an average recommendation of “Buy” from the five analysts that are presently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have updated their coverage on […]
More Stories
Eagle Point Credit Company Inc. Announces Dividend of $0.14 (NYSE:ECCC)
Eagle Point Credit Company Inc. (NYSE:ECCC – Get Free Report) declared a dividend on Saturday, January 11th,investing.com reports. Investors of...
Oracle Power (LON:ORCP) Shares Down 14.3% – What’s Next?
Oracle Power plc (LON:ORCP – Get Free Report) shares dropped 14.3% during mid-day trading on Saturday . The company traded...
Arctic Star Exploration (CVE:ADD) Stock Price Up 50% – Here’s What Happened
Arctic Star Exploration Corp. (CVE:ADD – Get Free Report)’s stock price was up 50% during mid-day trading on Saturday ....
Arctic Star Exploration (CVE:ADD) Stock Price Up 50% – Still a Buy?
Arctic Star Exploration Corp. (CVE:ADD – Get Free Report) shares rose 50% on Saturday . The company traded as high...
PHX Minerals (NYSE:PHX) & EQT (NYSE:EQT) Financial Contrast
EQT (NYSE:EQT – Get Free Report) and PHX Minerals (NYSE:PHX – Get Free Report) are both oils/energy companies, but which...
Invesque (TSE:IVQ.U) Stock Price Up 20% – What’s Next?
Shares of Invesque Inc (TSE:IVQ.U – Get Free Report) were up 20% during mid-day trading on Saturday . The stock...